Harbor Capital Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
261,721
-1,648
-0.6% -$6.01K 0.07% 357
2026
Q1
$1.04M Sell
263,369
-43,297
-14% -$218K 0.08% 318
2025
Q4
$2.08M Sell
306,666
-29,097
-9% -$204K 0.16% 165
2025
Q3
$2.34M Sell
335,763
-833,432
-71% -$5.79M 0.18% 146
2025
Q2
$7.14M Buy
1,169,195
+125,519
+12% +$835K 0.3% 105
2025
Q1
$7.93M Buy
1,043,676
+42,288
+4% +$353K 0.36% 86
2024
Q4
$9.63M Sell
1,001,388
-26,350
-3% -$205K 0.42% 67
2024
Q3
$6.07M Buy
1,027,738
+770,744
+300% +$5.11M 0.26% 114
2024
Q2
$1.78M Buy
+256,994
New +$1.81M 0.14% 230

Other funds holding MDXG

Harbor Capital Advisors's MDXG Position: Q2 2026 in Review

Harbor Capital Advisors reduced its MiMedx Group (MDXG) stake by 0.63% in Q2 2026, selling an estimated $6.01K and leaving 261,721 shares worth $1.01M. The position accounts for 0.07% of the portfolio, ranked #357.

Harbor Capital Advisors first reported a position in MDXG in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.63M in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Harbor Capital Advisors held 261,721 shares of MiMedx Group worth $1.01M as of Q2 2026.
  • Harbor Capital Advisors sold 1,648 MiMedx Group shares in Q2 2026, an estimated $6.01K.
  • MiMedx Group made up 0.07% of Harbor Capital Advisors's portfolio in Q2 2026, its #357 holding.
  • Harbor Capital Advisors first reported a position in MiMedx Group in Q2 2024 and has held it in 9 quarters since.
  • Harbor Capital Advisors's MiMedx Group position peaked at $9.63M in Q4 2024.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.